Gravatar

Shared by
beno

 

AKTX

Dec 2, 2019 09:44


Tags:

Swing Backside Scalping LIVE Intraday Backside First Test Confluence-VWAP

Fundamentals

N/a

Catalysts / News / Painting the picture

Akari Therapeutics Announces Pivotal Phase III Trial Design of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA), Following FDA Meeting

Technical Analysis

-Daily chart shows many signs of dilution (upside wicks, price closing weak when volume present)
-Price pumped $1 in PM
-Backside right off the open, clear downtrend, below VWAP all day
-Levels: 2.40, 2.60, 3

Original Plan / Strategy

Trade 1: First Test short of 2.40 zone
Trade 2: First Test short of 2.25 zone

Review

Trades were good, first was successful, second was a scratch.


Execution detail:

Date/time Symbol Side Price Position
2019-12-02 09:44:39 AKTX sell $2.390 short
2019-12-02 09:46:53 AKTX buy $2.270 0
2019-12-02 10:05:38 AKTX sell $2.240 short
2019-12-02 10:11:23 AKTX buy $2.250 0


Leave a comment about this trade!

You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes just a few seconds to sign up, and it's free!

View plans, Sign up for free, or Log in